Track the メディキット株式会社 stock price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, メディキット株式会社 has recorded 13 public disclosures. Market capitalisation: €40.6bn. The latest transaction was reported on 26 August 2025 (Holding update). Among the most active insiders: Takashi Nakajima. The full history is free.
13
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 3,673 of 28,102 companies
71.3
score / 100
Value
73
Quality
70
FCF yld3.1%
Earn yld7.4%
EV/EBITDA6.2x
ROE6.5%
Gross mgn38%
Net mgn13%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Medikit is a company specializing in the health and pharmaceutical sector, listed on the XTKS market. It focuses on the development and manufacturing of medical and pharmaceutical products.